MKI67 and breast carcinoma: Gallen 2013 immunohistochemical (IHC) classification, IHC biomarkers, including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 can be used as molecular subtypes in breast cancer [3].